What Stakeholders Think About CER: Now in a Booklet and at a Conference Near You

June 25, 2013

When you say “CER,” what are people thinking? The findings from NPC’s annual survey of health care stakeholders and their opinions of comparative effectiveness research and the environment for decision-making are now available in a new booklet (print and online as a PDF, along with an archived webinar). According to the survey results, stakeholders have growing expectations for the use of CER as a tool for improving health care decision-making. Their views also have changed from previous years in terms of which organizations were expected to play a significant role in specific aspects of CER, such as research priorities, methods and standards.

The survey’s findings further detail where stakeholders expect CER to go within the next 3-5 years, and what organizations they expect to lead each aspect of funding and conducting the research.

NPC research staff are presenting the survey results at two meetings this week. Health Research Services Director Kimberly Westrich will deliver remarks tomorrow at the Drug Information Association Annual Meeting in Boston, and Research Associate Adam Lustig presented a poster at the AcademyHealth Annual Research Meeting in Baltimore, Maryland.

Newsletter Volume

E.V.I.dently September 2014

Message From NPCPatient Access to Medicines: A Growing ChallengeFor health care consumers, the rationale for why some medicines are covered by their...
Blog Post

CER Tweets of the Week: Patient Engagement a Common Theme Among CER Stakeholders (September 22-26)

Patient engagement was a hot topic among comparative effectiveness research (CER) stakeholders on Twitter this week. @SUMedicine bioethicist David...
Blog Post

CER Tweets of the Week: NPC & GWU Health Care Policy Fellowship, JCER Joins Twitter, PCORI Appoints Methodology Committee Members (September 15-19)

This week, Tweeps invited colleagues to apply for the National Pharmaceutical Council and Milken Institute School of Public Health at The George...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
YouTube Videos

CER and the Environment for Health Care Decision-Making

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is continuing to shed light on the current environment...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
YouTube Videos

Developing Usability Criteria for Comparative Effectiveness Research

Avalere Health Senior Manager Sung Hee Choe outlines her work with the National Health Council to bring stakeholders together to develop the criteria...
Blog Post

CER Tweets of the Week: Patient Engagement a Common Theme Among CER Stakeholders (September 22-26)

Patient engagement was a hot topic among comparative effectiveness research (CER) stakeholders on Twitter this week. @SUMedicine bioethicist David...
Blog Post

CER Tweets of the Week: NPC & GWU Health Care Policy Fellowship, JCER Joins Twitter, PCORI Appoints Methodology Committee Members (September 15-19)

This week, Tweeps invited colleagues to apply for the National Pharmaceutical Council and Milken Institute School of Public Health at The George...
Blog Post

CER Tweets of the Week: NPC at CEVR Symposium & Vox.com on the Cochrane Collaboration (September 8-12)

This week, comparative effectiveness research (CER) stakeholders tweeted from Tufts’ Center for the Evaluation of Value and Risk in Health Symposium...
Blog Post

CER Tweets of the Week: Big Data, Informed Consent and What PCORI Stakeholders Really Think (September 1-5)

This week, comparative effectiveness research (CER) stakeholders tweeted about the Society for Medical Decision Making’s (@socmdm) 36th Annual North...

Research

  •  
  • 1 of 13
  • >

Commentary & Testimony